Director Dealing

Summary by AI BETAClose X

4basebio PLC announced that on February 10, 2026, Non-executive Directors Dr. Heikki Lanckriet and Mr. Hansjörg Plaggemars acquired 3,000 ordinary shares at 575.82 pence each and 1,000 ordinary shares at 585.00 pence each, respectively. Following these purchases, Dr. Lanckriet's shareholding increased to 1,122,688 shares, representing 7.23% of the issued share capital, while Mr. Plaggemars' aggregate holding with associated persons is 7,667 shares, or 0.05% of the issued share capital. The total issued share capital of the company is 15,538,518 ordinary shares.

Disclaimer*

Companies

4basebio (4BB)
UK 100

Latest directors dealings